Global Program Regulatory Manager/ Sr. Global Program Regulatory Manager
August 28, 2018
East Hanover, New Jersey
Full Time - Experienced
Pharmaceuticals, Quality/Risk Management, US Regulatory Affairs, Worldwide Regulatory Affairs
The Global Program Regulatory Manager (GPRM) works with some independence under limited supervision to provide strategic and operational regulatory direction and may support the Regulatory Affairs (RA) global program team (GPT) representative and/or GTAL for programs through development, registration and approval/post approval. The GPRM ensures the execution of regulatory plans in line with global regulatory strategy in close collaboration with the DRA GPT representative and/or GTAL. In certain cases, the GPRM may act as the GPT representative. The GPRM is a member of the DRA subteam and may indirectly report to the DRA GPT representative for the project and may have responsibility for leading regional DRA subteams.
Regulatory Strategy Responsible for implementing regulatory strategy and managing operational activities for assigned regions. Provides input into global regulatory strategy and contributes to Regulatory Functional Plan (RFP) and Seed Document, or their equivalents, including identification of gaps or risks in global strategic plan for assigned regions. Partners with regions to align on regulatory strategy in order to fullfill business objectives. Implements RFP across assigned regions. Works with DRA GPT representative and/or GTAL to plan and facilitate presentations to Novartis regulatory boards on regulatory strategy Coordinates and implements regulatory readiness with other line functions, Country Pharma Organizations and key opinion leaders. Works with DRA GPT representative and/or GTAL to interact with regulatory consultants/advisors for strategy input and challenge. Represents DRA on or leads sub-teams as required. HA Interactions Determines requirements and sets objectives for Health Authority (HA) interactions with DRA GPT representative and/or GTAL. Interacts directly with HAs as appropriate in meetings with DRA GPT representative and/or GTAL. Coordinates and plans rehearsals for HA meetings. Facilitates preparation and finalization of briefing books. Develops and implements plans for timely response to HA requests and coordinates responses. May serve as local HA liaison depending on location (e.g., FDA or EMA). Submissions and Approvals Responsible for integrating global strategy into regional submissions worldwide. Contributes to identification of issues, gaps, and tradeoffs affecting optimal and timely submission and approval. Coordinates, plans, and prepares for submission of dossiers in assigned regions worldwide. Review of global dossier summary documents. Contributes to development and implementation of plans to avoid/minimize clock stops during submission review. Responsible for submission of Clinical Trial Applications (CTAs) and Investigational New Drugs (INDs). Participates in negotiations for approvals as required with DRA GPT representative and/or GTAL. Responsible for facilitating timely submission and approval of dossiers with HAs under the guidance of the DRA GPT representative and/or GTAL. 2 Prescribing Information • Contributes to the development of the Development Core Data Sheet (DCDS) and Core Data Sheet (CDS)with DRA GPT representative and/or GTAL
GPRM - Science based BS or MS with requisite experience and demonstrated capability. Advanced degree (MD, Ph D, PharmD) preferred. English Experience with regulatory submission and approval processes in 1 or more major regions. • Experience in a global/matrix environment or cross-functional teams in the pharmaceutical industry. • Experience in HA negotiations. • 2-4 years involvement in regulatory and drug/biologic development spanning activities in Phases I-IV in the following areas: 1. Innovation in regulatory strategy. 2. Understanding of post-marketing/brand optimization strategies and commercial awareness preferred. 3. Involvement in an dossier submissions and approvals 4. HA negotiations. 5. Drug regulatory submission and commercialization in region. 3 6. Analysis and interpretation efficacy and safety data. 7. Regulatory operational expertise. Strong interpersonal, communication, negotiation and problem solving skills. Basic organizational awareness (e.g., interrelationship of departments, business priorities).
Sr. GPRM - Science based BS or MS with requisite experience and demonstrated capability. Advanced degree (MD, Ph D, PharmD) preferred. Languages: Fluency in English as a business language. Additional language is an asset. Experience: • Strong knowledge of regulatory submission and approval processes in 1 or more major regions. • Experience leading regulatory submissions and approvals in at least 1 major region. • Experience in a global/matrix environment or cross-functional teams in the pharmaceutical industry. • Experience in HA negotiations. • 4-6 years involvement in regulatory and drug/biologic development spanning activities in Phases I-IV in the following areas: 1. Innovation in regulatory strategy. 2. Prior history with post-marketing/brand optimization strategies and commercial awareness preferred. 3. Involvement in dossier submissions and approvals. 4. HA negotiations 5. Drug regulatory submissions and commercialization in major regions.
The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Internal Number: 248431BR
About Novartis Pharmaceuticals
The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines we provide to patients, physicians and healthcare organizations.
This growing business develops and markets patent-protected prescription drugs for important health needs. Our products are concentrated in major therapeutic areas: Cardiovascular/Metabolism, Oncology, Neuroscience, Dermatology, Arthritis Bone, Respiritory, Infectious Disease, Transplant, Opthalmics, GI, Urinary.
We have received 15 new pharmaceutical product approvals in the US since 2000, the most of any pharmaceutical company. Our current product portfolio includes more than 45 key marketed products, many of which are leaders in their respective therapeutic areas. The product development pipeline involves nearly 140 projects – including potential new products as well as potential new indications or formulations for existing products – in various stages of clinical development.
Industry experts have ranked Novartis as a leader for having one of the best combinations of organic growth, pipeline opportunities, and low patent-risk exposure among major companies in the pharmaceuticals industry